ZimVie’s new Mobi-C disc earns FDA approval

ZimVie earned FDA approval for its new version of the Mobi-C cervical disc, the devicemaker said Aug. 10.

Advertisement

The new version is smaller with a 4.5mm height and comes in seven footprints, according to a news release. The disc is approved for reconstruction of a cervical disc at both one and two levels.

“Surgeons will be able to use the prostheses in more significantly collapsed discs and avoid over-distraction of the facet joints,” spine surgeon Jad Khalil, MD, said in the release. “This will expand the indications for cervical disc arthroplasty and therefore more patients can benefit from the clinically compelling Mobi-C cervical disc.”

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

  • Aurora Spine saw $4.4 million dollars in first-quarter sales, a less than 1% increase year over year, according to financial…

Advertisement

Comments are closed.